Mr. Speaker, the government has reserved 414 million doses of COVID-19 vaccines with six private sector contracts. What will this cost taxpayers? For 70 years, government-owned Connaught Labs developed low-cost vaccines and other medicines. This model would ensure the financial viability of a universal pharmacare program in Canada.
Will the government return to this model of publicly owned laboratories to develop low-cost medicines and vaccines to serve the greater good?